Moneycontrol PRO
HomeNewsBusinessMarketsDAILY VOICE | Smart money to move to large private banks, autos, construction, consumption: Dhananjay Sinha of JM Financial

DAILY VOICE | Smart money to move to large private banks, autos, construction, consumption: Dhananjay Sinha of JM Financial

Sinha expects the downside will be limited from here on, and he still maintains a target of 15700 on the Nifty by end of the year.

May 19, 2021 / 11:26 IST

Dhananjay Sinha, Managing Director & Chief – Strategist, JM Financial Institutional Securities Limited, is of the view that if the second wave is contained either through effective vaccination or natural immunisation, then the strength in the market should continue.

Sinha has over 20 years of experience in Indian financial markets. Prior to joining JM Financial, Sinha worked with Systematix Group, IDFC Securities, Emkay Global Financial Services, Centrum Broking, Infosys, ICICI Bank, JM Morgan Stanley, Times Bank etc.

In an interview with Moneycontrol's Kshitij Anand, Sinha said that the downside will be limited from here on, and he still maintains a target of 15700 on the Nifty by end of the year.

Edited excerpts:-

Q) The second wave is not yet over for India, and the third wave is expected to hit in October. Do you think the market has factored in third-wave impact? What is the kind of impact you see on markets, as well as earnings?

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

A) The market is still grappling with the impact of the second wave, and at the moment it is not factoring in a scenario of a third wave. As of now, we do not exactly know the impact of the ongoing wave in terms of earnings and revenue numbers, etc.

But, we definitely know that growth expectations are being scaled down with real GDP growth in light of the second wave. Optimism around a strong rebound in FY22 has blunted with consensus projection at 10.5-11% edging towards 9.5-10%. We are closer to 9%.

The general expectation is that the second wave should subside by end of May and June is likely to be better. Hence, the impact of the second wave is seen as temporary.

The market has been resilient with benchmark indices down by 3-4% from the peak in February 2021 after rising by more than 100% from the First wave bottom in March 2020.

If the second wave is indeed short and we get to a reasonable level of immunisation through vaccination or natural immunisation through recovery from infected cases by end of July, then the strength in the market should continue.

However, if the second wave stretches and is followed by a thid wave, the Indian market can continue to underperform.

The possibility of a large crack is limited in my view.

Q) Small & midcaps have remained resilient in the past few months but with most businesses remain shut on account of lockdown that could continue for some more time – do you think the outperformance will continue?

A) While the benchmark indices have remained resilient, we saw some FII sell-off of about USD 1.5-2 billion, which is very modest compared to the massive reversal in March 2020.

Sector indices that saw max impact were cyclical- banks, autos, capital goods, realty, etc., especially where FIIs had larger exposure.

Hence, the midcaps held by domestic investors have continued to perform better. In my view, if the the second wave is indeed short and things become better after May or June, it is likely that the largecaps, and good quality cyclicals can outperform

Q) The Warren Buffett indicator is above Long Term Averages at 92%, according to a report. It has come down from a high of 105 in FY21. Do you see this as a sign of caution?

A) Mcap to GDP has been a poor indicator of market performance. The better thing to look at is the money supply to GDP.

In the context of rising money supply and declining velocity of money, financial asset prices tend to bloat. Hence, the key thing is dollar supply, policy rates, and inflation outlook.

Q) Where do you see smart money moving in various sectors and why?

A) Large private banks, autos, construction, consumption

Q) From an FII perspective, how is India placed in terms of valuations when compared to global peers. Are we still attractive?

A) India’s valuations have seen a steep rebound to levels higher than the past 10-year average. But, that is generally the case across the world.

India FII flows is mainly a function of global liquidity and rates outlook scenario and to some extent growth differential. At the moment, fears of high US inflation are feeding into the early winding of QEs by the Fed and earlier than expected lift-off.

Secondly, India is also facing growth concerns arising from Wave 2. All these are impacting FII flows in the near term. In our view if these concerns are temporary then there should be a revival in FII flows in the coming months.

Q) Which are the key risk to the current bull market? Nifty is down by about 5% from the highs – do you see more downside before things stabalise and why?

A) I think the downside will be limited. I still maintain the Nifty target of 15700 by end of the year.

Q) According to CMIE report, 11 lakh jobs have gone amid rise in COVID. This will hit the economy and earnings of India Inc. Do you think this will put the banking and financial sector including NBFCs at a risk in the near term?

A) We think the financial sector is fairly stable. Large banks are endowed with good capital buffer, they have provided for NPAs substantially, and have large liquidity in their book. So they should be able to withstand near-term stress very well.

Disclaimer: The views and investment tips expressed by experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Kshitij Anand
Kshitij Anand is the Editor Markets at Moneycontrol.
first published: May 19, 2021 07:56 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347